Markers of inflammation and cellular adhesion molecules in relation to insulin resistance in nondiabetic elderly: The Rotterdam Study

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 9, 2001, Pages 4398-4405

  Hak, A Elisabeth ^a   Pols, Huibert A P ^a   Stehouwer, Coen D A ^b   Meijer, John ^c   Kiliaan, Amanda J ^c   Hofman, Albert ^a   Breteler, Monique M B ^a   Witteman, Jacqueline C M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c NUMICO RESEARCH   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; C REACTIVE PROTEIN; CELL ADHESION MOLECULE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; VASCULAR CELL ADHESION MOLECULE 1;

ACUTE PHASE RESPONSE; AGE; AGED; ARTICLE; BODY DISTRIBUTION; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL ADHESION; CHOLESTEROL BLOOD LEVEL; CYTOKINE PRODUCTION; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE MARKER; ELDERLY CARE; FEMALE; GENDER; HUMAN; INFLAMMATION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; OBESITY; POPULATION RISK; PREVALENCE; PRIORITY JOURNAL; REGRESSION ANALYSIS; SMOKING;

EID: 0034855391     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.86.9.7873     Document Type: Article

References (46)

1. Banting lecture 1988. Role of insulin resistance in human disease
2. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension
3. Hyperinsulinaemia: The key feature of a cardiovascular and metabolic syndrome
4. Diabetes mellitus, impaired glucose tolerance, and hyperinsulinemia in an elderly population. The Rotterdam Study
5. The pathogenesis of atherosclerosis: A perspective for the 1990s
6. NIDDM as a disease of the innate immune system: Association of acute-phase reactants and interleukin-6 with metabolic syndrome X
7. Chronic subclinical inflammation as part of the insulin resistance syndrome. The insulin resistance atherosclerosis study (IRAS)
8. C-reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction: A potential role for cytokines originating from adipose tissue?
9. Involvement of the hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris
10. Insulin resistance syndrome and fibrinolytic activity: The Northern Sweden MONICA Study
11. Effects of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins
12. Lipids, lipoproteins, and apoproteins in serum during infection
13. Increased levels of soluble adhesion molecules in type 2 (non-insulin dependent) diabetes mellitus are independent of glycaemic control
14. Elevated levels of soluble E-selectin in patients with IDDM and NIDDM: Relation to metabolic control
15. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon
16. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis
17. Determinants of disease and disability in the elderly: The Rotterdam Elderly Study
18. Cholesterol determinations. A comparative study of methods with special reference to enzymatic procedures
19. Strategies for the prevention of coronary heart disease: A policy statement of the European Atherosclerosis Society
20. World Health Organization-International Society of Hypertension guidelines for the management of hypertension. Guidelines Subcommittee
21. Methodology of the modular ECG analysis system MEANS
22. The diagnostic performance of computer programs for the interpretation of electrocardiograms
23. Prevalence, determinants, and misclassification of myocardial infarction in the elderly
24. Prevalence of stroke in the general population. The Rotterdam Study
25. Peripheral arterial disease in the elderly: The Rotterdam Study
26. Why use the oral glucose tolerance test?
27. How good a marker is insulin level for insulin resistance?
28. Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance
29. Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome
30. Is type II diabetes mellitus a disease of the innate immune system?
31. Regulation of the acute phase response by cytokines
32. Tumor necrosis factor alpha: A key component of the obesity-diabetes link
33. Tumor necrosis factor alpha inhibits signaling from the insulin receptor
34. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities Study): A cohort study
35. Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women
36. Insulin is a prominent modulator of the cytokine-stimulated expression of acute-phase plasma protein genes
37. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: The Atherosclerosis Risk in Communities (ARIC) Study
38. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men
39. Cross-sectional study of soluble intercellular adhesion molecule-1 and cardiovascular risk factors in apparently healthy men
40. Levels of soluble cell adhesion molecules in patients with dyslipidemia
41. Direct proinflammatory effect of C-reactive protein on human endothelial cells
42. Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells
43. Increased expression in vivo of VCAM-1 and E-selectin by the aortic endothelium of normolipemic and hyperlipemic diabetic rabbits
44. Inhibition of mononuclear cell recruitment in aortic intima by treatment with anti-ICAM-1 and anti-LFA-1 monoclonal antibodies in hypercholesterolemic rats: Implications of the ICAM-1 and LFA-1 pathway in atherogenesis